{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:01:15Z","timestamp":1777780875471,"version":"3.51.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH118827"],"award-info":[{"award-number":["R01MH118827"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH116582"],"award-info":[{"award-number":["R01MH116582"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS105200"],"award-info":[{"award-number":["R01NS105200"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS064025"],"award-info":[{"award-number":["R01NS064025"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG067025"],"award-info":[{"award-number":["R01AG067025"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54HD090256"],"award-info":[{"award-number":["U54HD090256"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50HD105353"],"award-info":[{"award-number":["P50HD105353"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wisconsin Distinguished Graduate Fellowship"},{"name":"Jenni and Kyle Professorship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fragile X syndrome (FXS), the most prevalent inherited intellectual disability and one of the most common monogenic forms of autism, is caused by a loss of fragile X messenger ribonucleoprotein 1 (FMR1). We have previously shown that FMR1 represses the levels and activities of ubiquitin ligase MDM2 in young adult FMR1-deficient mice, and treatment by a MDM2 inhibitor Nutlin-3 rescues both hippocampal neurogenic and cognitive deficits in FMR1-deficient mice when analyzed shortly after the administration. However, it is unknown whether Nutlin-3 treatment can have long-lasting therapeutic effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We treated 2-month-old young adult FMR1-deficient mice with Nutlin-3 for 10 days and then assessed the persistent effect of Nutlin-3 on both cognitive functions and adult neurogenesis when mice were 6-month-old mature adults. To investigate the mechanisms underlying the persistent effects of Nutlin-3, we analyzed the proliferation and differentiation of neural stem\/progenitor cells isolated from these mice and assessed the transcriptome of the hippocampal tissues of treated mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that transient treatment with Nutlin-3 of 2-month-old young adult FMR1-deficient mice prevents the emergence of neurogenic and cognitive deficits in mature adult FXS mice at 6 months of age. We further found that the long-lasting restoration of neurogenesis and cognitive function might not be mediated by changing intrinsic properties of adult neural stem cells. Transcriptomic analysis of the hippocampal tissue demonstrated that transient Nultin-3 treatment leads to significant expression changes in genes related to the extracellular matrix, secreted factors, and cell membrane proteins in the FMR1-deficient hippocampus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data indicates that transient Nutlin-3 treatment in young adults leads to long-lasting neurogenic and behavioral changes likely through modulating adult neurogenic niche that impact adult neural stem cells. Our results demonstrate that cognitive impairments in FXS may be prevented by an early intervention through Nutlin-3 treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-022-02370-9","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T21:02:54Z","timestamp":1652389374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Sustained correction of hippocampal neurogenic and cognitive deficits after a brief treatment by Nutlin-3 in a mouse model of fragile X syndrome"],"prefix":"10.1186","volume":"20","author":[{"given":"Sahar","family":"Javadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5128-4424","authenticated-orcid":false,"given":"Xinyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"issue":"12","key":"2370_CR1","first-page":"1","volume":"4","author":"F Tassone","year":"2013","unstructured":"Tassone F, Iong KP, Tong T-H, Lo J, Gane LW, Berry-Kravis E, et al. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med. 2013;4(12):1\u201313.","journal-title":"Genome Med"},{"issue":"5","key":"2370_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1159\/000330213","volume":"33","author":"DB Budimirovic","year":"2011","unstructured":"Budimirovic DB, Kaufmann WE. What can we learn about autism from studying fragile X syndrome? Dev Neurosci. 2011;33(5):379\u201394.","journal-title":"Dev Neurosci"},{"issue":"Supplement 3","key":"2370_CR3","doi-asserted-by":"publisher","first-page":"S194","DOI":"10.1542\/peds.2016-1159F","volume":"139","author":"WE Kaufmann","year":"2017","unstructured":"Kaufmann WE, Kidd SA, Andrews HF, Budimirovic DB, Esler A, Haas-Givler B, et al. Autism spectrum disorder in fragile X syndrome: cooccurring conditions and current treatment. Pediatrics. 2017;139(Supplement 3):S194\u2013206.","journal-title":"Pediatrics."},{"issue":"4","key":"2370_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0092-8674(91)90125-I","volume":"66","author":"M Pieretti","year":"1991","unstructured":"Pieretti M, Zhang F, Fu Y-H, Warren ST, Oostra BA, Caskey CT, et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991;66(4):817\u201322.","journal-title":"Cell."},{"issue":"5","key":"2370_CR5","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","volume":"65","author":"AJ Verkerk","year":"1991","unstructured":"Verkerk AJ, Pieretti M, Sutcliffe JS, Fu Y-H, Kuhl DP, Pizzuti A, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65(5):905\u201314.","journal-title":"Cell."},{"issue":"1","key":"2370_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mcn.2009.09.013","volume":"43","author":"S De Rubeis","year":"2010","unstructured":"De Rubeis S, Bagni C. Fragile X mental retardation protein control of neuronal mRNA metabolism: insights into mRNA stability. Mol Cell Neurosci. 2010;43(1):43\u201350.","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"2370_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuron.2008.10.004","volume":"60","author":"GJ Bassell","year":"2008","unstructured":"Bassell GJ, Warren ST. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron. 2008;60(2):201\u201314.","journal-title":"Neuron."},{"issue":"4","key":"2370_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41583-021-00432-0","volume":"22","author":"JD Richter","year":"2021","unstructured":"Richter JD, Zhao X. The molecular biology of FMRP: new insights into fragile X syndrome. Nat Rev Neurosci. 2021;22(4):209\u201322.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2370_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41556-020-00618-1","volume":"23","author":"T Kurosaki","year":"2021","unstructured":"Kurosaki T, Imamachi N, Proschel C, Mitsutomi S, Nagao R, Akimitsu N, et al. Loss of the fragile X syndrome protein FMRP results in misregulation of nonsense-mediated mRNA decay. Nat Cell Biol. 2021;23(1):40\u20138.","journal-title":"Nat Cell Biol."},{"issue":"4","key":"2370_CR10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2014.03.040","volume":"157","author":"R Alpatov","year":"2014","unstructured":"Alpatov R, Lesch BJ, Nakamoto-Kinoshita M, Blanco A, Chen S, St\u00fctzer A, et al. A chromatin-dependent role of the fragile X mental retardation protein FMRP in the DNA damage response. Cell. 2014;157(4):869\u201381.","journal-title":"Cell."},{"issue":"6","key":"2370_CR11","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ejhg.2008.61","volume":"16","author":"KB Garber","year":"2008","unstructured":"Garber KB, Visootsak J, Warren ST. Fragile X syndrome. Eur J Hum Genet. 2008;16(6):666\u201372.","journal-title":"Eur J Hum Genet"},{"key":"2370_CR12","doi-asserted-by":"publisher","unstructured":"Asiminas A, Jackson AD, Louros SR, Till SM, Spano T, Dando O, et al. Sustained correction of associative learning deficits after brief, early treatment in a rat model of Fragile X Syndrome. Sci Transl Med. 2019;11(494). https:\/\/doi.org\/10.1126\/scitranslmed.aao0498.","DOI":"10.1126\/scitranslmed.aao0498"},{"issue":"10","key":"2370_CR13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nrn4001","volume":"16","author":"JD Richter","year":"2015","unstructured":"Richter JD, Bassell GJ, Klann E. Dysregulation and restoration of translational homeostasis in fragile X syndrome. Nat Rev Neurosci. 2015;16(10):595\u2013605.","journal-title":"Nat Rev Neurosci"},{"issue":"7429","key":"2370_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature11737","volume":"492","author":"M Ascano","year":"2012","unstructured":"Ascano M, Mukherjee N, Bandaru P, Miller JB, Nusbaum JD, Corcoran DL, et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature. 2012;492(7429):382\u20136.","journal-title":"Nature."},{"key":"2370_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neuroscience.2013.04.058","volume":"246","author":"LE Dansie","year":"2013","unstructured":"Dansie LE, Phommahaxay K, Okusanya AG, Uwadia J, Huang M, Rotschafer SE, et al. Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice. Neuroscience. 2013;246:186\u201398.","journal-title":"Neuroscience."},{"issue":"3","key":"2370_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.5582\/irdr.2016.01045","volume":"5","author":"A Ligsay","year":"2016","unstructured":"Ligsay A, Hagerman RJ. Review of targeted treatments in fragile X syndrome. Intractable Rare Dis Res. 2016;5(3):158\u201367. https:\/\/doi.org\/10.5582\/irdr.2016.01045.","journal-title":"Intractable Rare Dis Res."},{"issue":"1","key":"2370_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1006\/excr.2000.4932","volume":"258","author":"CE Bakker","year":"2000","unstructured":"Bakker CE, de Diego OY, Bontekoe C, Raghoe P, Luteijn T, Hoogeveen AT, et al. Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp Cell Res. 2000;258(1):162\u201370.","journal-title":"Exp Cell Res"},{"issue":"4","key":"2370_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/ng0893-335","volume":"4","author":"D Devys","year":"1993","unstructured":"Devys D, Lutz Y, Rouyer N, Bellocq J-P, Mandel J-L. The FMR\u20131 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet. 1993;4(4):335\u201340.","journal-title":"Nat Genet"},{"key":"2370_CR19","doi-asserted-by":"crossref","unstructured":"Luo Y, Shan G, Guo W, Smrt RD, Johnson EB, Li X, et al. Fragile x mental retardation protein regulates proliferation and differentiation of adult neural stem\/progenitor cells. PLoS Genet. 2010;6(4).","DOI":"10.1371\/journal.pgen.1000898"},{"issue":"336","key":"2370_CR20","doi-asserted-by":"publisher","first-page":"336ra61","DOI":"10.1126\/scitranslmed.aad9370","volume":"8","author":"Y Li","year":"2016","unstructured":"Li Y, Stockton ME, Bhuiyan I, Eisinger BE, Gao Y, Miller JL, et al. MDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrome. Sci Transl Med. 2016;8(336):336ra61.","journal-title":"Sci Transl Med"},{"issue":"1","key":"2370_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-02088-w","volume":"9","author":"Y Li","year":"2018","unstructured":"Li Y, Stockton ME, Eisinger BE, Zhao Y, Miller JL, Bhuiyan I, et al. Reducing histone acetylation rescues cognitive deficits in a mouse model of Fragile X syndrome. Nat Commun. 2018;9(1):1\u201316.","journal-title":"Nat Commun"},{"issue":"5","key":"2370_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nm.2336","volume":"17","author":"W Guo","year":"2011","unstructured":"Guo W, Allan AM, Zong R, Zhang L, Johnson EB, Schaller EG, et al. Ablation of Fmrp in adult neural stem cells disrupts hippocampus-dependent learning. Nat Med. 2011;17(5):559\u201365.","journal-title":"Nat Med"},{"issue":"48","key":"2370_CR23","doi-asserted-by":"publisher","first-page":"E11397","DOI":"10.1073\/pnas.1809588115","volume":"115","author":"B Liu","year":"2018","unstructured":"Liu B, Li Y, Stackpole EE, Novak A, Gao Y, Zhao Y, et al. Regulatory discrimination of mRNAs by FMRP controls mouse adult neural stem cell differentiation. Proc Natl Acad Sci. 2018;115(48):E11397\u2013E405.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"2370_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/BPL-170052","volume":"4","author":"C Pinar","year":"2018","unstructured":"Pinar C, Yau S-y, Sharp Z, Shamei A, Fontaine CJ, Meconi AL, et al. Effects of voluntary exercise on cell proliferation and neurogenesis in the dentate gyrus of adult FMR1 knockout mice. Brain Plast. 2018;4(2):185\u201395.","journal-title":"Brain Plast"},{"issue":"6","key":"2370_CR25","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/hipo.20989","volume":"22","author":"O Lazarov","year":"2012","unstructured":"Lazarov O, Demars MP, Da Tommy ZK, Ali HM, Grauzas V, Kney A, et al. Impaired survival of neural progenitor cells in dentate gyrus of adult mice lacking fMRP. Hippocampus. 2012;22(6):1220\u20134.","journal-title":"Hippocampus."},{"issue":"2","key":"2370_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.nbd.2009.08.001","volume":"36","author":"B Eadie","year":"2009","unstructured":"Eadie B, Zhang W, Boehme F, Gil-Mohapel J, Kainer L, Simpson J, et al. Fmr1 knockout mice show reduced anxiety and alterations in neurogenesis that are specific to the ventral dentate gyrus. Neurobiol Dis. 2009;36(2):361\u201373.","journal-title":"Neurobiol Dis"},{"issue":"9","key":"2370_CR27","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018812","volume":"7","author":"G Kempermann","year":"2015","unstructured":"Kempermann G, Song H, Gage FH. Neurogenesis in the adult hippocampus. Cold Spring Harbor Perspect Biol. 2015;7(9):a018812.","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"46","key":"2370_CR28","doi-asserted-by":"publisher","first-page":"11785","DOI":"10.1523\/JNEUROSCI.3798-08.2008","volume":"28","author":"AJ Eisch","year":"2008","unstructured":"Eisch AJ, Cameron HA, Encinas JM, Meltzer LA, Ming G-L, Overstreet-Wadiche LS. Adult neurogenesis, mental health, and mental illness: hope or hype? J Neurosci. 2008;28(46):11785\u201391.","journal-title":"J Neurosci"},{"issue":"4","key":"2370_CR29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.stemcr.2021.01.019","volume":"16","author":"KR Babcock","year":"2021","unstructured":"Babcock KR, Page JS, Fallon JR, Webb AE. Adult hippocampal neurogenesis in aging and Alzheimer\u2019s disease. Stem Cell Rep. 2021;16(4):681\u201393.","journal-title":"Stem Cell Rep"},{"issue":"1","key":"2370_CR30","first-page":"23","volume":"78","author":"Consortium TD-BFX","year":"1994","unstructured":"Consortium TD-BFX. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell. 1994;78(1):23\u201333.","journal-title":"Cell."},{"issue":"9","key":"2370_CR31","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1097\/00001756-200006260-00037","volume":"11","author":"M Yamaguchi","year":"2000","unstructured":"Yamaguchi M, Saito H, Suzuki M, Mori K. Visualization of neurogenesis in the central nervous system using nestin promoter-GFP transgenic mice. Neuroreport. 2000;11(9):1991\u20136.","journal-title":"Neuroreport."},{"issue":"5","key":"2370_CR32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.neuron.2011.03.027","volume":"70","author":"W Guo","year":"2011","unstructured":"Guo W, Zhang L, Christopher DM, Teng Z-Q, Fausett SR, Liu C, et al. RNA-binding protein FXR2 regulates adult hippocampal neurogenesis by reducing Noggin expression. Neuron. 2011;70(5):924\u201338.","journal-title":"Neuron."},{"issue":"1","key":"2370_CR33","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1038\/s41467-020-18046-y","volume":"11","author":"X Zhao","year":"2020","unstructured":"Zhao X, van Praag H. Steps towards standardized quantification of adult neurogenesis. Nat Commun. 2020;11(1):4275.","journal-title":"Nat Commun."},{"key":"2370_CR34","doi-asserted-by":"crossref","unstructured":"Contestabile A, Greco B, Ghezzi D, Tucci V, Benfenati F, Gasparini L. Lithium rescues synaptic plasticity and memory in Down syndrome mice. J Clin Investig. 2012;123(1).","DOI":"10.1172\/JCI64650"},{"issue":"11","key":"2370_CR35","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1038\/nprot.2012.123","volume":"7","author":"W Guo","year":"2012","unstructured":"Guo W, Patzlaff NE, Jobe EM, Zhao X. Isolation of multipotent neural stem or progenitor cells from both the dentate gyrus and subventricular zone of a single adult mouse. Nat Protoc. 2012;7(11):2005.","journal-title":"Nat Protoc"},{"key":"2370_CR36","doi-asserted-by":"crossref","unstructured":"Gao Y, Shen M, Gonzalez JC, Dong Q, Kannan S, Hoang JT, et al. RGS6 mediates effects of voluntary running on adult hippocampalneurogenesis. Cell Rep. 2020;32(5):107997.","DOI":"10.1016\/j.celrep.2020.107997"},{"key":"2370_CR37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128.","journal-title":"BMC Bioinformatics."},{"issue":"17","key":"2370_CR38","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/bioinformatics\/btv300","volume":"31","author":"W Walter","year":"2015","unstructured":"Walter W, Sanchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31(17):2912\u20134.","journal-title":"Bioinformatics."},{"issue":"W1","key":"2370_CR39","doi-asserted-by":"publisher","first-page":"W212","DOI":"10.1093\/nar\/gkz446","volume":"47","author":"AB Keenan","year":"2019","unstructured":"Keenan AB, Torre D, Lachmann A, Leong AK, Wojciechowicz ML, Utti V, et al. ChEA3: transcription factor enrichment analysis by orthogonal omics integration. Nucleic Acids Res. 2019;47(W1):W212\u2013W24.","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"2370_CR40","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.tins.2004.05.013","volume":"27","author":"G Kempermann","year":"2004","unstructured":"Kempermann G, Jessberger S, Steiner B, Kronenberg G. Milestones of neuronal development in the adult hippocampus. Trends Neurosci. 2004;27(8):447\u201352.","journal-title":"Trends Neurosci"},{"issue":"3","key":"2370_CR41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/hmg\/ddr501","volume":"21","author":"W Guo","year":"2012","unstructured":"Guo W, Murthy AC, Zhang L, Johnson EB, Schaller EG, Allan AM, et al. Inhibition of GSK3\u03b2 improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome. Hum Mol Genet. 2012;21(3):681\u201391.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2370_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00441-017-2718-5","volume":"371","author":"BE Eisinger","year":"2018","unstructured":"Eisinger BE, Zhao X. Identifying molecular mediators of environmentally enhanced neurogenesis. Cell Tissue Res. 2018;371(1):7\u201321.","journal-title":"Cell Tissue Res"},{"issue":"7097","key":"2370_CR43","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/nature04957","volume":"441","author":"DT Scadden","year":"2006","unstructured":"Scadden DT. The stem-cell niche as an entity of action. Nature. 2006;441(7097):1075\u20139.","journal-title":"Nature."},{"issue":"5769","key":"2370_CR44","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1126\/science.1110542","volume":"311","author":"KA Moore","year":"2006","unstructured":"Moore KA, Lemischka IR. Stem cells and their niches. Science. 2006;311(5769):1880\u20135.","journal-title":"Science."},{"issue":"32-33","key":"2370_CR45","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1002\/adma.200802582","volume":"21","author":"MP Lutolf","year":"2009","unstructured":"Lutolf MP, Blau HM. Artificial stem cell niches. Adv Mater. 2009;21(32-33):3255\u201368.","journal-title":"Adv Mater"},{"issue":"2","key":"2370_CR46","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.stem.2020.01.002","volume":"26","author":"J Kjell","year":"2020","unstructured":"Kjell J, Fischer-Sternjak J, Thompson AJ, Friess C, Sticco MJ, Salinas F, et al. Defining the adult neural stem cell niche proteome identifies key regulators of adult neurogenesis. Cell Stem Cell. 2020;26(2):277\u201393. e8.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2370_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ydbio.2005.05.009","volume":"284","author":"J Zhang","year":"2005","unstructured":"Zhang J, Li L. BMP signaling and stem cell regulation. Dev Biol. 2005;284(1):1\u201311.","journal-title":"Dev Biol"},{"issue":"4","key":"2370_CR48","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.stemcr.2019.02.011","volume":"12","author":"AN Ziegler","year":"2019","unstructured":"Ziegler AN, Feng Q, Chidambaram S, Testai JM, Kumari E, Rothbard DE, et al. Insulin-like growth factor II: an essential adult stem cell niche constituent in brain and intestine. Stem Cell Rep. 2019;12(4):816\u201330.","journal-title":"Stem Cell Rep"},{"key":"2370_CR49","doi-asserted-by":"crossref","unstructured":"Sutcu HH, Ricchetti M. Loss of heterogeneity, quiescence, and differentiation in muscle stem cells. Stem Cell Invest. 2018;5.","DOI":"10.21037\/sci.2018.03.02"},{"key":"2370_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fnmol.2021.654031","volume":"14","author":"M Stevanovic","year":"2021","unstructured":"Stevanovic M, Drakulic D, Lazic A, Ninkovic DS, Schwirtlich M, Mojsin M. SOX transcription factors as important regulators of neuronal and glial differentiation during nervous system development and adult neurogenesis. Front Mol Neurosci. 2021;14:51.","journal-title":"Front Mol Neurosci"},{"issue":"7222","key":"2370_CR51","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nature07391","volume":"456","author":"M Francois","year":"2008","unstructured":"Francois M, Caprini A, Hosking B, Orsenigo F, Wilhelm D, Browne C, et al. Sox18 induces development of the lymphatic vasculature in mice. Nature. 2008;456(7222):643\u20137.","journal-title":"Nature."},{"issue":"9","key":"2370_CR52","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1523\/JNEUROSCI.4586-12.2013","volume":"33","author":"K Shimozaki","year":"2013","unstructured":"Shimozaki K, Clemenson GD, Gage FH. Paired related homeobox protein 1 is a regulator of stemness in adult neural stem\/progenitor cells. J Neurosci. 2013;33(9):4066\u201375.","journal-title":"J Neurosci"},{"issue":"6","key":"2370_CR53","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.stem.2011.04.001","volume":"8","author":"L Panman","year":"2011","unstructured":"Panman L, Andersson E, Alekseenko Z, Hedlund E, Kee N, Mong J, et al. Transcription factor-induced lineage selection of stem-cell-derived neural progenitor cells. Cell Stem Cell. 2011;8(6):663\u201375.","journal-title":"Cell Stem Cell"},{"key":"2370_CR54","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.3389\/fcell.2020.621644","volume":"8","author":"AC Silva","year":"2021","unstructured":"Silva AC, Pereira C, Fonseca ACR, Pinto-do-\u00d3 P, Nascimento DS. Bearing my heart: the role of extracellular matrix on cardiac development, homeostasis, and injury response. Front Cell Dev Biol. 2021;8:1705.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"2370_CR55","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.0.CO;2-4","volume":"22","author":"BK Hall","year":"2000","unstructured":"Hall BK, Miyake T. All for one and one for all: condensations and the initiation of skeletal development. Bioessays. 2000;22(2):138\u201347.","journal-title":"Bioessays."},{"key":"2370_CR56","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fcell.2020.00457","volume":"8","author":"H Hu","year":"2020","unstructured":"Hu H, Lin S, Wang S, Chen X. The role of transcription factor 21 in epicardial cell differentiation and the development of coronary heart disease. Front Cell Dev Biol. 2020;8:457.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"2370_CR57","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nrd.2017.221","volume":"17","author":"EM Berry-Kravis","year":"2018","unstructured":"Berry-Kravis EM, Lindemann L, J\u00f8nch AE, Apostol G, Bear MF, Carpenter RL, et al. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nat Rev Drug Discov. 2018;17(4):280\u201399.","journal-title":"Nat Rev Drug Discov"},{"key":"2370_CR58","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuropharm.2018.05.004","volume":"147","author":"MR Tranfaglia","year":"2019","unstructured":"Tranfaglia MR, Thibodeaux C, Mason DJ, Brown D, Roberts I, Smith R, et al. Repurposing available drugs for neurodevelopmental disorders: the fragile X experience. Neuropharmacology. 2019;147:74\u201386.","journal-title":"Neuropharmacology."},{"issue":"6","key":"2370_CR59","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2174\/138161211795222586","volume":"17","author":"P Secchiero","year":"2011","unstructured":"Secchiero P, Bosco R, Celeghini C, Zauli G. Recent advances in the therapeutic perspectives of Nutlin-3. Curr Pharm Des. 2011;17(6):569\u201377.","journal-title":"Curr Pharm Des"},{"issue":"43","key":"2370_CR60","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1038\/onc.2012.640","volume":"32","author":"A Rufini","year":"2013","unstructured":"Rufini A, Tucci P, Celardo I, Melino G. Senescence and aging: the critical roles of p53. Oncogene. 2013;32(43):5129\u201343.","journal-title":"Oncogene."},{"issue":"8","key":"2370_CR61","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000935","volume":"2","author":"R Beckerman","year":"2010","unstructured":"Beckerman R, Prives C. Transcriptional regulation by p53. Cold Spring Harbor Perspect Biol. 2010;2(8):a000935.","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"2370_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155418","volume":"140","author":"T Sheikh","year":"2021","unstructured":"Sheikh T, Sen E. p53 affects epigenetic signature on SOCS1 promoter in response to TLR4 inhibition. Cytokine. 2021;140:155418.","journal-title":"Cytokine."},{"issue":"10","key":"2370_CR63","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1101\/gad.299198.117","volume":"31","author":"A Tovy","year":"2017","unstructured":"Tovy A, Spiro A, McCarthy R, Shipony Z, Aylon Y, Allton K, et al. p53 is essential for DNA methylation homeostasis in na\u00efve embryonic stem cells, and its loss promotes clonal heterogeneity. Genes Dev. 2017;31(10):959\u201372.","journal-title":"Genes Dev"},{"issue":"12","key":"2370_CR64","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1101\/gad.298984.117","volume":"31","author":"AJ Levine","year":"2017","unstructured":"Levine AJ, Berger SL. The interplay between epigenetic changes and the p53 protein in stem cells. Genes Dev. 2017;31(12):1195\u2013201.","journal-title":"Genes Dev"},{"issue":"6","key":"2370_CR65","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/j.1460-9568.2011.07599.x","volume":"33","author":"G Kempermann","year":"2011","unstructured":"Kempermann G. Seven principles in the regulation of adult neurogenesis. Eur J Neurosci. 2011;33(6):1018\u201324.","journal-title":"Eur J Neurosci"},{"issue":"7","key":"2370_CR66","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/jcmm.12298","volume":"18","author":"M Kandasamy","year":"2014","unstructured":"Kandasamy M, Lehner B, Kraus S, Sander PR, Marschallinger J, Rivera FJ, et al. TGF-beta signalling in the adult neurogenic niche promotes stem cell quiescence as well as generation of new neurons. J Cell Mol Med. 2014;18(7):1444\u201359.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"2370_CR67","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/stem.1688","volume":"32","author":"AM Bond","year":"2014","unstructured":"Bond AM, Peng CY, Meyers EA, McGuire T, Ewaleifoh O, Kessler JA. BMP signaling regulates the tempo of adult hippocampal progenitor maturation at multiple stages of the lineage. Stem Cells. 2014;32(8):2201\u201314.","journal-title":"Stem Cells."},{"issue":"6","key":"2370_CR68","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ajhg.2018.10.009","volume":"103","author":"X Zhao","year":"2018","unstructured":"Zhao X, Bhattacharyya A. Human models are needed for studying human neurodevelopmental disorders. Am J Hum Genet. 2018;103(6):829\u201357.","journal-title":"Am J Hum Genet."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02370-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02370-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02370-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T07:06:59Z","timestamp":1668323219000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02370-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2370"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02370-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.01.14.476402","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,13]]},"assertion":[{"value":"5 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments have been approved by the Institutional Animal Care and Use Committee at the University of Wisconsin-Madison.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors agree to publish this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"XZ and YL are inventors of a patent (\u201cMethods for treating cognitive deficits associated with fragile x syndrome\u201d United States US 9,962,380 B2). The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"163"}}